Cancers,
Год журнала:
2024,
Номер
17(1), С. 74 - 74
Опубликована: Дек. 29, 2024
Magnetic
resonance
imaging
(MRI)
currently
serves
as
the
primary
diagnostic
method
for
glioma
detection
and
monitoring.
The
integration
of
neurosurgery,
radiation
therapy,
pathology,
radiology
in
a
multi-disciplinary
approach
has
significantly
advanced
its
diagnosis
treatment.
However,
prognosis
remains
unfavorable
due
to
treatment
resistance,
inconsistent
response
rates,
high
recurrence
rates
after
surgery.
These
factors
are
closely
associated
with
complex
molecular
characteristics
tumors,
internal
heterogeneity,
relevant
external
microenvironment.
complete
removal
gliomas
presents
challenges
their
infiltrative
growth
pattern
along
white
matter
fibers
perivascular
space.
Therefore,
it
is
crucial
comprehensively
understand
features
analyze
tumor
heterogeneity
order
accurately
characterize
quantify
invasion
range.
multi-parameter
quantitative
MRI
technique
provides
an
opportunity
investigate
microenvironment
aggressiveness
tumors
at
cellular,
blood
perfusion,
cerebrovascular
levels.
this
review
examines
current
applications
research
explores
prospects
future
development.
Tomography,
Год журнала:
2024,
Номер
10(11), С. 1780 - 1797
Опубликована: Ноя. 11, 2024
Head
and
neck
cancer
represents
the
seventh
most
common
neoplasm
worldwide,
with
squamous
cell
carcinoma
being
represented
histologic
variant.
The
rising
incidence
of
neoplastic
pathology
this
district,
coupled
drastic
changes
in
its
epidemiology
over
past
decades,
have
posed
significant
challenges
to
physicians
worldwide
terms
diagnosis,
prognosis,
treatment.
In
order
meet
these
challenges,
a
considerable
amount
effort
has
been
spent
by
authors
recent
literature
explore
new
technologies
their
possible
employment
for
better
diagnostic
prognostic
definition
head
(HNSCC).
Among
technologies,
growing
interest
gathering
around
applications
dual-energy
computed
tomography
(DECT)
pathology.
Dual-energy
utilizes
two
distinct
X-ray
energy
spectra
obtain
datasets
single
scan,
allowing
material
differentiation
based
on
unique
attenuation
profiles.
DECT
offers
key
benefits
such
as
enhanced
contrast
resolution,
reduced
beam-hardening
artifacts,
precise
iodine
quantification
through
monochromatic
reconstructions.
It
also
creates
decomposition
images,
like
maps,
aiding
tumor
characterization
therapy
assessment.
This
paper
aims
summarize
findings
use
HNSCC,
providing
comprehensive
overview
aid
further
research
exploration
field.
Cancers,
Год журнала:
2024,
Номер
16(22), С. 3845 - 3845
Опубликована: Ноя. 15, 2024
Patients
with
gliomas
show
an
increased
risk
of
spontaneous
hemorrhages
throughout
the
disease.
Simultaneously,
number
patients
taking
acetylsalicylic
acid
(ASA)
for
primary
and
secondary
prophylaxis
is
rising
in
daily
clinical
practice,
interrupting
ASA
intake
before
elective
or
emergency
intracranial
surgery
not
always
feasible.
This
study
aims
to
evaluate
risks
associated
continuing
use
perioperatively
while
focusing
on
hemorrhage
potential
thromboembolic
events
that
may
arise
from
discontinuing
ASA,
particularly
multimorbid
undergoing
glioma
surgery.
Brain Sciences,
Год журнала:
2024,
Номер
14(12), С. 1178 - 1178
Опубликована: Ноя. 25, 2024
Background/Objectives:
Magnetic
Resonance
Imaging
(MRI)
plays
a
vital
role
in
brain
tumor
diagnosis
by
providing
clear
visualization
of
soft
tissues
without
the
use
ionizing
radiation.
Given
increasing
incidence
tumors,
there
is
an
urgent
need
for
reliable
diagnostic
tools,
as
misdiagnoses
can
lead
to
harmful
treatment
decisions
and
poor
outcomes.
While
machine
learning
has
significantly
advanced
medical
diagnostics,
achieving
both
high
accuracy
computational
efficiency
remains
critical
challenge.
Methods:
This
study
proposes
hybrid
model
that
integrates
MobileNetV2
feature
extraction
with
Support
Vector
Machine
(SVM)
classifier
classification
tumors.
The
was
trained
validated
using
Kaggle
MRI
dataset,
which
includes
7023
images
categorized
into
four
types:
glioma,
meningioma,
pituitary
tumor,
no
tumor.
MobileNetV2’s
efficient
architecture
leveraged
extraction,
SVM
used
enhance
accuracy.
Results:
proposed
showed
excellent
results,
Area
Under
Curve
(AUC)
scores
0.99
0.97
1.0
tumors
class.
These
findings
highlight
MobileNetV2-SVM
not
only
improves
but
also
reduces
overhead,
making
it
suitable
broader
clinical
use.
Conclusions:
demonstrates
substantial
potential
enhancing
diagnostics
offering
balance
precision
efficiency.
Its
ability
maintain
while
operating
efficiently
could
better
outcomes
practice,
particularly
resource
limited
settings.
Children,
Год журнала:
2024,
Номер
11(12), С. 1463 - 1463
Опубликована: Ноя. 29, 2024
Background/Objectives:
Intracranial
arachnoid
cysts
(ACs)
may
be
congenital,
primary,
or
secondary
due
to
trauma.
These
are
benign,
contain
cerebrospinal
fluid
(CSF),
and
classified
based
on
location,
size,
their
clinical
symptomatology.
They
uncommon
lesions
in
children,
rarely
leading
severe
mass-effect
neurological
Methods:
The
present
report
describes
a
30-month-old
female
presenting
with
quadriparesis.
An
emergency
magnetic
resonance
imaging
(MRI)
study
revealed
the
presence
of
primary
intracranial
cyst
posterior
cranial
fossa,
exerting
significant
pressure
medulla
oblongata
cervical
portion
spinal
cord,
displacing
them
dorsally,
remnant
diameter
2.5
mm.
Results:
This
benign
malformation
located
crucial
area
might
have
been
complicated
by
deterioration
required
prompt
intervention,
so
patient
underwent
suboccipital
craniectomy
sitting
position,
along
neurosurgical
procedure,
which
established
lasting
communication
channel
between
basal
cisterns.
led
favorable
outcome.
Conclusions:
Up
report,
postoperative
complete
resolution
quadriparesis
fossa
has
not
reported.
At
present,
no
therapeutic
modality
as
definitive
standard
care
for
pediatric
ACs,
management
raises
great
deal
controversy
among
neurosurgeons.
narrative
literature
review
integrates
various
perspectives
regarding
ACs
possible
treatment
approaches
that
currently
available.
Brain Sciences,
Год журнала:
2024,
Номер
14(12), С. 1253 - 1253
Опубликована: Дек. 13, 2024
The
current
standard
of
care
for
brain
tumor
management
includes
maximal
safe
surgical
resection
followed
by
concurrent
chemotherapy
and
radiation
therapy.
Recent
advances
in
image-guided
techniques
have
enhanced
the
precision
resections,
yet
there
remains
a
critical
need
innovative
technologies
to
further
improve
patient
outcomes.
Techniques
such
as
fluorescence
neurosurgery
combination
with
stereotactic
radiosurgery
improved
outcomes
patients
tumors.
In
this
article
Brain
Science’s
Special
Issue
Advances
Translational
Neuro-Oncology,
we
review
use
treatment
addition,
summarize
emerging
theranostic
nanoparticles
delivery
diagnostic
therapeutic
enable
neurosurgeon
perform
more
precise
resections
operating
room,
specifically
target
existing
novel
treatments
cells,
augment
efficacy
radiosurgery.
These
translational
tools
will
allow
neurosurgeons,
neuro-oncologists,
oncologists
go
“beyond
knife”
survival
patients.
Cancers,
Год журнала:
2024,
Номер
17(1), С. 74 - 74
Опубликована: Дек. 29, 2024
Magnetic
resonance
imaging
(MRI)
currently
serves
as
the
primary
diagnostic
method
for
glioma
detection
and
monitoring.
The
integration
of
neurosurgery,
radiation
therapy,
pathology,
radiology
in
a
multi-disciplinary
approach
has
significantly
advanced
its
diagnosis
treatment.
However,
prognosis
remains
unfavorable
due
to
treatment
resistance,
inconsistent
response
rates,
high
recurrence
rates
after
surgery.
These
factors
are
closely
associated
with
complex
molecular
characteristics
tumors,
internal
heterogeneity,
relevant
external
microenvironment.
complete
removal
gliomas
presents
challenges
their
infiltrative
growth
pattern
along
white
matter
fibers
perivascular
space.
Therefore,
it
is
crucial
comprehensively
understand
features
analyze
tumor
heterogeneity
order
accurately
characterize
quantify
invasion
range.
multi-parameter
quantitative
MRI
technique
provides
an
opportunity
investigate
microenvironment
aggressiveness
tumors
at
cellular,
blood
perfusion,
cerebrovascular
levels.
this
review
examines
current
applications
research
explores
prospects
future
development.
